SCHEMBL6089526

SCHEMBL6089526

Cc1[nH]c(/C=C2/C(=O)NN=C2c2cccs2)c(C(C)C)c1CCCN(C)c1ccncc1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.39
CHEK1 O14757 3/20 0.39
ALK Q9UM73 1/20 0.36
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
NTSR1 P30989 1/20 0.31
HTT P42858 1/20 0.31
RECQL P46063 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6088472 0.88 ALK (0.38) KDRCHEK1ALKMAPTALDH1A1
SCHEMBL6088479 0.88 ALK (0.38) KDRCHEK1ALKMAPTALDH1A1
SCHEMBL6089145 0.87 KDR (0.42) KDRCHEK1ALDH1A1LMNA
SCHEMBL6090568 0.86 KDR (0.51) KDRCHEK1ALKMAPTALDH1A1
SCHEMBL6088622 0.85 KDR (0.42) KDRCHEK1
SCHEMBL7490843 0.85 KDR (0.42) KDRCHEK1ALDH1A1LMNA
SCHEMBL6089537 0.85 ALK (0.38) KDRCHEK1ALKMAPTALDH1A1
SCHEMBL6088164 0.84 KDR (0.45) KDRCHEK1
SCHEMBL6092623 0.84 KDR (0.41) KDRCHEK1ALDH1A1LMNA
SCHEMBL6090358 0.84 KDR (0.42) KDRCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7060822-B1 2-pyrazolin-5-ones ABBOTT GMBH & CO. KG (DE) 2006-06-13 US disclosed
EP-1218373-A2 2-PYRAZOLIN-5-ONES AS TYROSINE KINASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2002-07-03 EP disclosed
WO-2001009121-A2 2-PYRAZOLIN-5-ONES_AS TYROSINE KINASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-02-08 WO disclosed